Latest Insider Transactions at Statera Biopharma, Inc. (STAB)
This section provides a real-time view of insider transactions for Statera Biopharma, Inc. (STAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Statera Biopharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Statera Biopharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2021
|
Taunia Markvicka Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Sep 09
2021
|
Randy S. Saluck Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+49.94%
|
-
|
|
Sep 09
2021
|
Lea Verny Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+50.0%
|
-
|
|
Sep 09
2021
|
Steve K Barbarick Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+50.0%
|
-
|
|
Jul 27
2021
|
Michael K Handley President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
296,609
+50.0%
|
-
|
|
Jul 27
2021
|
Peter Aronstam Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
141,370
+50.0%
|
-
|
|
Jul 27
2021
|
Cozette M. Mc Avoy Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,947
+50.0%
|
-
|
|
Jul 27
2021
|
Clifford Selsky Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
101,579
+50.0%
|
-
|
|
Jul 27
2021
|
Robert Buckheit Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,378
+50.0%
|
-
|
|
Jul 22
2021
|
Langdon L Miller Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$30,000
$3.0 P/Share
|